FI901103A0 - Förfarande för framställning av N-substituerade aminoalkandifosfonsyror - Google Patents

Förfarande för framställning av N-substituerade aminoalkandifosfonsyror

Info

Publication number
FI901103A0
FI901103A0 FI901103A FI901103A FI901103A0 FI 901103 A0 FI901103 A0 FI 901103A0 FI 901103 A FI901103 A FI 901103A FI 901103 A FI901103 A FI 901103A FI 901103 A0 FI901103 A0 FI 901103A0
Authority
FI
Finland
Prior art keywords
substituted
preparation
formula
image
metabolism
Prior art date
Application number
FI901103A
Other languages
English (en)
Finnish (fi)
Other versions
FI95264B (sv
FI95264C (sv
Inventor
Knut A Jaeggi
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI901103A0 publication Critical patent/FI901103A0/sv
Publication of FI95264B publication Critical patent/FI95264B/sv
Application granted granted Critical
Publication of FI95264C publication Critical patent/FI95264C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3873Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
FI901103A 1989-03-08 1990-03-05 Förfarande för framställning av N-substituerade aminoalkandifosfonsyror FI95264C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH86689 1989-03-08
CH86689 1989-03-08

Publications (3)

Publication Number Publication Date
FI901103A0 true FI901103A0 (sv) 1990-03-05
FI95264B FI95264B (sv) 1995-09-29
FI95264C FI95264C (sv) 1996-01-10

Family

ID=4197009

Family Applications (1)

Application Number Title Priority Date Filing Date
FI901103A FI95264C (sv) 1989-03-08 1990-03-05 Förfarande för framställning av N-substituerade aminoalkandifosfonsyror

Country Status (21)

Country Link
US (1) US5036058A (sv)
EP (1) EP0387194B1 (sv)
JP (1) JPH02279689A (sv)
KR (1) KR900014413A (sv)
AT (1) ATE117308T1 (sv)
AU (1) AU629298B2 (sv)
CA (1) CA2011586A1 (sv)
DD (1) DD297824A5 (sv)
DE (1) DE59008275D1 (sv)
DK (1) DK0387194T3 (sv)
ES (1) ES2067010T3 (sv)
FI (1) FI95264C (sv)
HU (1) HU206120B (sv)
IE (1) IE64984B1 (sv)
IL (1) IL93586A (sv)
MX (1) MX19785A (sv)
NO (1) NO174152C (sv)
NZ (1) NZ232805A (sv)
PH (1) PH26923A (sv)
PT (1) PT93353B (sv)
ZA (1) ZA901742B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4015715A1 (de) * 1990-05-16 1991-11-21 Bayer Ag Neuartige oligophosphate mit antiviraler wirkung
IE912115A1 (en) * 1990-06-25 1992-01-01 Takeda Chemical Industries Ltd Bisphosphonic acid derivatives, their production and use
US5159108A (en) * 1990-09-18 1992-10-27 Merck & Co., Inc. Process for preparing an antihypercalcemic agent
IE914417A1 (en) * 1990-12-19 1992-07-01 Takeda Chemical Industries Ltd Bisphosphonic acid derivatives, their production and use
IT1244698B (it) * 1991-02-01 1994-08-08 Gentili Ist Spa Acidi aril-o arilalchil-acil ammino-alchil-idrossidifosfonici, procedimento per la loro preparazione e loro uso in terapia osteo-articolare e dei tessuti connettori in generale
ATE147396T1 (de) * 1991-08-27 1997-01-15 Ciba Geigy Ag N-substituierte aminomethandiphosphonsäuren
EP0541037A3 (en) * 1991-11-06 1997-02-26 Takeda Chemical Industries Ltd Squalene synthetase inhibitory composition and use thereof
US5283057A (en) * 1992-04-24 1994-02-01 The Procter & Gamble Company Risedronate in oral compositions
JP2006176499A (ja) * 2004-11-25 2006-07-06 Nippon Seibutsu Seizai:Kk 眼疾患治療剤
FR2926081B1 (fr) * 2008-01-03 2010-02-19 Univ Nantes Derives d'acide hydroxy-bisphosphonique comme vecteur ciblant le tissu osseux
FR2973378B1 (fr) 2011-03-28 2013-10-04 Atlanthera Derives d'acide hydroxybisphosphonique bifonctionnels

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3203308A1 (de) * 1982-01-27 1983-07-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Diphosphonsaeure-derivate und diese enthaltende pharmazeutische praeparate
FR2531088B1 (fr) * 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
GB8419489D0 (en) * 1984-07-31 1984-09-05 Leo Pharm Prod Ltd Chemical compounds
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
IT1187828B (it) * 1985-05-24 1987-12-23 Gentili Ist Spa Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
EP0243173B1 (en) * 1986-04-24 1991-06-26 Fujisawa Pharmaceutical Co., Ltd. New diphosphonic acid compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
GB8618259D0 (en) * 1986-07-25 1986-09-03 Leo Pharm Prod Ltd Pharmaceutical compositions
ES2039259T3 (es) * 1986-11-21 1993-09-16 Ciba-Geigy Ag Procedimiento para la obtencion de acidos azacicloalquil alcandifosfonicos aromaticamente substituidos.
US4933472A (en) * 1988-04-08 1990-06-12 Yamanouchi Pharmaceutical Co., Ltd. Substituted aminomethylenebis(phosphonic acid) derivatives

Also Published As

Publication number Publication date
AU629298B2 (en) 1992-10-01
NO901077L (no) 1990-09-10
HUT53112A (en) 1990-09-28
MX19785A (es) 1994-03-31
DD297824A5 (de) 1992-01-23
PT93353B (pt) 1996-02-29
CA2011586A1 (en) 1990-09-08
PT93353A (pt) 1990-11-07
NZ232805A (en) 1992-06-25
PH26923A (en) 1992-12-03
NO174152B (no) 1993-12-13
HU901348D0 (en) 1990-05-28
ES2067010T3 (es) 1995-03-16
AU4988490A (en) 1990-09-13
EP0387194A1 (de) 1990-09-12
NO901077D0 (no) 1990-03-07
KR900014413A (ko) 1990-10-23
EP0387194B1 (de) 1995-01-18
IE900809L (en) 1990-09-08
DK0387194T3 (da) 1995-03-20
FI95264B (sv) 1995-09-29
US5036058A (en) 1991-07-30
HU206120B (en) 1992-08-28
IL93586A0 (en) 1990-12-23
IL93586A (en) 1995-06-29
NO174152C (no) 1994-03-23
FI95264C (sv) 1996-01-10
ATE117308T1 (de) 1995-02-15
ZA901742B (en) 1990-10-31
DE59008275D1 (de) 1995-03-02
JPH02279689A (ja) 1990-11-15
IE64984B1 (en) 1995-09-20

Similar Documents

Publication Publication Date Title
HUT47529A (en) Process for producing polyethyleneglycol-carbaminates and diagnostic and pharmaceutical compositions comprising such compounds
FI901103A0 (sv) Förfarande för framställning av N-substituerade aminoalkandifosfonsyror
HUT59394A (en) Process for producing piperazine derivatives and pharmaceutical compositions comprising same
TW198039B (sv)
GB1322639A (en) Indoline derivatives and a process for the manufacture thereof
ES8303279A1 (es) "procedimiento para preparar nuevos derivados de acidos fenil-alifatico-carboxilicos".
HUT63409A (en) Process for producing 4-amino-2-ureidopyrimidine-5-carboxylic acid amide derivatives and pharmaceutical compositions comprising same
YU47723B (sh) Postupak za dobivanje derivata 2-imino-3-heterocikloalkilbenzotiazolina
GR74116B (sv)
HUT47900A (en) Process for producing new amides of butenic acid and pharmaceutical compositions containing them as active components
HUT47897A (en) Process for producing salicilates and pharmaceutical compositions containing them
FI884177A0 (fi) Foerfarande foer framstaellning av l-aminsyror.
SE7714526L (sv) Sett att framstella 2-amino-cyklopent-1-en-1-tiokarbonyl-disulfider

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MM Patent lapsed
MM Patent lapsed

Owner name: NOVARTIS AG